to participate in DCAT Week, 2022
Boonton, NJ – March 03, 2022 – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly- owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that the company will participate in DCAT® Week 2022 being held March 21-24, 2022 in New York City.
GET YOUR FREE COPY
Meet Enteris Biopharma at DCAT Week 2022
Fill out our contact form below if you’d like to arrange a time to discuss how we can help with your next drug product development.